carmustine has been researched along with Primary Myelofibrosis in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, T | 1 |
| Kunze, KL | 1 |
| Temkit, M | 1 |
| Partain, DK | 1 |
| Patnaik, MS | 1 |
| Slack, JL | 1 |
| Khera, N | 1 |
| Hogan, WJ | 1 |
| Roy, V | 1 |
| Noel, P | 1 |
| Leis, JF | 1 |
| Sproat, LZ | 1 |
| Fauble, V | 1 |
| Mesa, RA | 1 |
| Palmer, J | 1 |
| Rancea, M | 1 |
| Will, A | 1 |
| Borchmann, P | 1 |
| Monsef, I | 1 |
| Engert, A | 1 |
| Skoetz, N | 1 |
| Meerkin, D | 1 |
| Ashkenazi, Y | 1 |
| Gottschalk-Sabag, S | 1 |
| Hershko, C | 1 |
1 review available for carmustine and Primary Myelofibrosis
| Article | Year |
|---|---|
Plasma cell dyscrasia with marrow fibrosis. A reversible syndrome mimicking agnogenic myeloid metaplasia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Diagnosis, Diffe | 1994 |
2 other studies available for carmustine and Primary Myelofibrosis
| Article | Year |
|---|---|
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Carmustine; Chimerism; Female; Graft vs Host Disease; | 2019 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine | 2014 |